FITC-Galacto-RGD 2 ) and anti-human integrin α v β 3 antibody (sc-7312, 2.0 g/mL, BD Biosciences, San Jose, CA). After washing with PBS three times, the tumor cells were incubated with Cy3-conjugated goat anti-mouse antibodies (1:100, V/V, Jackson Immuno-Research Inc., West Grove, PA) for another hour at room temperature. After washing with PBS buffer, the slides were mounted with Dapi Fluormount G (SouthernBiotech, Birmingham, AL) and cover glass. Fluorescence was visualized with an Olympic BX51 fluorescence microscope (Olympus America Inc., Center Valley, PA). Images were acquired using a Hamamatsu digital CCD camera ORCA-R2 (Hamamatsu Photonics K.K., Japan) with Olympus MetaMorph software. All pictures were taken under 400 × magnifications with the same exposure time. Brightness and contrast adjustments were made equally to all images. The overlays were made using Olympus MetaMorph software. were rinsed with ice-cold PBS for 5 min, and then incubated with 1% BSA in PBS for 30 min on ice to block non-specific binding. Tumor cells were incubated with 10 M FITC-labeled cyclic RGD peptides (FITC-RGD 2 , FITC-3P-RGD 2 or FITC-Galacto-RGD 2 ) for 2 h on ice. After washing with PBS buffer, tumor cells were analyzed for fluorescent intensity. In overlay experiments, tumor cells were incubated with 1% BSA in PBS for 30 min on ice, and then incubated for 2 h on ice with 10 M FITC-conjugated cyclic RGD peptide and anti-human integrin α v β 3 antibody (sc-7312: 2.0 g/mL). After washing with PBS buffer, tumor cells were then incubated for another 1 h on ice with Cy3-conjugated goat anti-mouse antibodies (1:100, V/V). In the blocking experiments, U87MG glioma cells were incubated for 2 h with 10 µM FITC-Galacto-RGD 2 in the presence of 1 mM c(RGDfK) 2 . FITC-3P-RGK 2 (10 µM) was used as negative control to demonstrate RGD specificity of cyclic RGD peptides for integrin α v β 3 . Figure SI3 . Selected microscopic images (Magnification: 400×) of U87MG glioma cells stained with FITC-conjugated cyclic RGD peptides (Green) and mouse anti-human integrin  v  3 antibody (sc-7312) detected with Cy3 conjugated goat anti-mouse antibody (red). Blue color indicates the presence of nuclei stained with DAPI. In the overlay images, orange and yellow colors indicate co-localization of FITC-labeled cyclic RGD peptides (Top: FITC-RGD 2 ; Middle: FITC-3P-RGD 2 ; Bottom: FITC-Galacto-RGD 2 ) with sc-7312. Co-incubation of FITC-RGD 2 , FITC-3P-RGD 2 or FITC-Galacto-RGD 2 with antiintegrin  v  3 antibody resulted in positive staining of U87MG glioma cells. The fluorescence intensity on tumor cells stained with FITC-RGD 2 was slightly lower than that stained with FITC-3P-RGD 2 and FITC-Galacto-RGD 2 , due to its lower integrin α v β 3 /α v β 5 binding affinity. The fluorescence signals distributed throughout the entire U87MG tumor cells. Nuclear localization was also observed for FITC-RGD 2 , FITC-3P-RGD 2 and FITC-Galacto-RGD 2 . The orange and yellow colors in the overlay images clearly indicated the co-localization of FITC-conjugated cyclic RGD peptides and anti-integrin  v  3 antibody. FITC-3P-RGD 2 and FITC-Galacto-RGD 2 were useful as fluorescent probes for integrin α v β 3 /α v β 5 staining of U87MG cells. 
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